Results 221 to 230 of about 524,132 (248)

Unraveling the Molecular Mechanisms of Glioma Recurrence: A Study Integrating Single‐Cell and Spatial Transcriptomics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Glioma recurrence severely impacts patient prognosis, with current treatments showing limited efficacy. Traditional methods struggle to analyze recurrence mechanisms due to challenges in assessing tumor heterogeneity, spatial dynamics, and gene networks.
Lei Qiu, Yinjiao Fei, Jiaxuan Ding, Kexin Shi, Jinyan Luo, Yuchen Zhu, Xingjian Sun, Gefei Jiang, Yuandong Cao, Weilin Xu, Shu Zhou   +10 more
wiley   +1 more source

Development and Characterization of Active Pectin-Curdlan Biopolymer Films with Cannabigerol (CBG) Oil as Innovative Materials with Plant Metabolism-Stimulating Properties and Potential to Extend the Postharvest Shelf Life of Blackberries (<i>Black Satin</i>) Fruits. [PDF]

Polymers (Basel)
Dobrucka R, Paterska M, Szymański M.
europepmc   +1 more source

Assessment of the feed additive consisting of coated granulated cobalt(II) carbonate for ruminants with functional rumen, equidae, lagomorphs, rodents, herbivore reptiles and zoo mammals for the renewal of its authorisation (Dox-al Italia SpA). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Theodoridou K, Mantovani A, Gropp J, Woursten R, Holczknecht O, Galobart J, Gkimprixi E, Pizzo F, Vettori MV, Navarro-Villa A.   +24 more
europepmc   +1 more source

Peer review of the pesticide risk assessment of the active substance ziram. [PDF]

EFSA J
European Food Safety Authority (EFSA), Álvarez F, Arena M, Auteri D, Leite SB, Binaglia M, Castoldi AF, Chiusolo A, Colagiorgi A, Colas M, Crivellente F, De Lentdecker C, De Magistris I, Egsmose M, Fait G, Ferilli F, Santonja GG, Gouliarmou V, Halling K, Ippolito A, Istace F, Kardassi D, Kienzler A, Lanzoni A, Lava R, Leuschner R, Linguadoca A, Romano ML, Louisse J, Lythgo C, Magrans O, Mangas I, Mioč A, Miron I, Molnar T, Padovani L, Padricello V, Panzarea M, Parra Morte JM, Rizzuto S, Santos M, Serafimova R, Sharp R, Szentes C, Theobald A, Tiramani M, Vianello G, Villamar-Bouza L.   +47 more
europepmc   +1 more source

Real-world data on the abuse potential of medications for the treatment of insomnia: a disproportionality analysis of the FAERS database. [PDF]

Front Pharmacol
Saskin P, McCall WV, Neubauer DN, Crucitti A, Perry B, Luyet PP, Jaziri R, Vaillant C.   +7 more
europepmc   +1 more source

Non-invasive neurostimulation techniques for the treatment of stimulant use disorders. [PDF]

Front Psychiatry
Hendy J, Bereznicki H, Lundin RM.
europepmc   +1 more source

Multi-level Risk and Protective Factors for Vaping Onset and Escalation Among Youth: a Focus on LGBTQ + Disparities. [PDF]

Prev Sci
Anjorin O, Asghari-Kamrani A, Lindley L, Mandell CJ, Nakkash R, Griffin KW.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MASI: microbiota—active substance interactions database

Nucleic Acids Research, 2021
Xian Zeng, Jiajun Fan, Ying Tan
exaly  

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

Lancet, The, 2013
Harvey A Whiteford, Louisa J Degenhardt, Jürgen Rehm   +2 more
exaly